NUDT1 and neoplasm: Additional unspecific effects on cellular viability have been described for compounds binding to tubulin, e.g., Gul et al. showed that the preclinical used MTH1 inhibitor TH588 showed decreased tumor growth due to involvement in microtubule spindle regulation instead of the first investigated target effect [19,71].